Skip to content

Effect of Ayurvedic Formulations in the treatment of Kamala (Jaundice)

A Clinical Study to Evaluate the Effect of Ayurvedic Formulations in the management of Kamla (Jaundice) w.s.r. to Impaired Liver Function

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/04/013527
Enrollment
15
Registered
2018-04-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- patients with impaired LFT

Interventions

Intervention1: Kamalahar Yoga , Nishoth Churna with sharakara: i.Trivrita (Nishotha) churna with Sharkara 5g twice a day for 7 days ii. Ayurvedic formulation (syrup Kamlahar yoga) 10ml tds for 30 days

Sponsors

Principal
Lead Sponsor
Ayush Pharmaceuticals
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient willing to undergo trial and ready to give written consent. 2. Between the age group of 10 years and 70 years. 3. Patients presenting with signs and symptoms of Kamla and those having impaired liver function test. 4. Clinical evidence of infective hepatitis,cirrhosis of liver,parenchymal disease of liver,alcoholic liver disease etc.

Exclusion criteria

Exclusion criteria: 1.Patients not willing for trial. 2.Patients who have developed malignancy and acute hepatocellular failure. 3.Patient in whom there is need of surgery, in case of obstructive jaundice. 4.Patients who have inherited hemoglobinopathy such as sickle cell anemia or thalassemia

Design outcomes

Primary

MeasureTime frame
awaitedTimepoint: June 2018

Secondary

MeasureTime frame
Evaluation of course of Jaundice with the given intervention, demographic pattern of the pathologyTimepoint: june 2018

Countries

India

Contacts

Public ContactDr Uma Thakur

RG GOVT PG AYURVEDIC COLLEGE P APROLA HP

mehra_bl@rediffmail.com9418017165

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026